Past Award Winners

Annemarie E. Fogerty, MD

Instructor of Medicine, Harvard Medical School, Boston, MA

Mentor: Dr. Walter H. Dzik
Project Title: Mechanmism of Gestational Thrombocytopenia
Project Description: Dr. Fogerty's study has two components: (1) to establish a bio-bank of prospectively collected antepartum and postpartum samples of plasma and DNA - linked to clinical data - obtained from women with GT and from a matched cohort of women with normal pregnancy; and (2) to analyze a pilot group of these samples for polymorphisms of the A 1 domain of the von Willebrand factor gene. The hypothesis of this proposal is that the increased shear blood flow of the gravid uterus results in an abnormal (increased) interaction between vWF and platelets in patients with GT. The bio-bank that we propose to develop through this application will serve as an important platform for subsequent studies of the mechanism of GT and for research leading to the development of a rapid diagnostic test for the disorder. 

Chelsea Kebodeaux, MD

Pediatric and Adolescent Gynecology Fellow, Baylor College of Medicine

Mentor: Dr. Oluyemisi Adeyemi-Fowode
Project Title: Alternate-day versus daily oral iron therapy in adolescents with iron deficiency anemia and heavy menstrual bleeding: a randomized clinical trial.
Project Description: Dr. Kebodeaux's study aims to optimize the treatment of iron deficiency anemia due to heavy menstrual bleeding. The results of her project will provide valuable pilot data that can be expanded upon to improve the treatment of iron deficiency anemia in adolescent females with heavy menstrual bleeding and bleeding disorders which in turn lead to improved quality of life for patients.

Jerome Jeffrey Federspiel, MD, PhD

Maternal Fetal Medicine Fellow, Duke University Medical Center, Durham, NC

Mentor: Dr. Andra H. James
Project Title: Preventing venous thromboembolism following ccesarean delivery: building evidence to inform practice
Project Description: This study will set out to determine the incidence of VTE following cesarean delivery, for patients considered to be at elevated risk of VTE and thus requiring prophylaxis based on commonly-used guidelines. Secondly, this study will develop a decision sciences model which can be used to model the benefits, risks, and costs of implementation of the disparate guidelines on a cohort of patients intended to simulate the current use of cesarean delivery in the United States. 

Julia Coleman, MD

Mentor: Dr. Christopher C. Silliman

Project Title: Sex Dimorphisms in Trauma-Induced Coagulopathy: A Mechanistic Exploration of a Sex-Specific Survival Benefit Project Description: Dr. Coleman will investigate whether sex hormones affect clot formation and stability, thrombin formation and platelet function in vitro and whether differential levels of sex hormones in vivo may confer differential thrombelastographic profiles in female populations and outcomes in female trauma patients.

Click Here to Read Dr. Coleman's Story

Tazim Dowlut-McElroy, MD, MS

Mentors: Julie L. Strickland MD, MPH; Shannon L. Carpenter, MD, MS

Project Title: Use of Levonorgestrel-Releasing Intrauterine Device for the Treatment of Heavy Menstrual Bleeding in Adolescents with Bleeding Disorder

Click Here to Read Dr. Dowlu-McElory's Story

Margo Rollins, MD

Pediatric Hematologist

Mentor:  Robert Sidonio, Jr., MD, MSc

Project: Determine the feasibility and utility of a novel point of care device (Anemocheck) in the monitoring of reduction of hemoglobin during the menstrual cycle in symptomatic Hemophilia A or B carriers

Ruchika P. Sharma, MD

Pediatric Hematologist

Mentor: Veronica Flood, MD

Project: Coagulating Disorders in Menstruating Adolescent Females

Click Here to Read Dr. Sharma's Story

Deva Sharma, MD

Pediatric Hematologist

Mentor: Michael DeBaun, MD

Project: Epidemiologic study of acute vaso-occlusive pain associated with menstruation in women with sickle cell disease

Click Here to Read Dr. Sharma's Story

Leslie Skeith, MD

Hematologist

Mentor: Marc Rodger, MD

Project: Exploring the concept of a minimal clinically important difference in women with antiphospholipid syndrome and past pregnancy loss